Accent Microcell

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Q5D01013
  • NSEID: ACCENTMIC
  • BSEID:
INR
332.75
-8.6 (-2.52%)
BSENSE

Dec 05

BSE+NSE Vol: 21500

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Accent Microcell Ltd stock-summary
stock-summary
Accent Microcell Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Accent Microcell Ltd was originally incorporated on April 10, 2012 as a Private Limited Company as "Accent Microcell Private Limited" with the Registrar of Companies, Gujarat. The Company converted from a Private Limited Company to Public Limited Company and , the name was changed to `Accent Microcell Limited' and a Fresh Certificate of Incorporation was issued on December 23, 2022 by the Registrar of Companies, Ahmedabad.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 23.99 Cr
Number of Shares
2.4 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
04-Jun-2025
2.4
23.99
2946020
10
Right Issues
13-Dec-2023
2.1
21.04
5600000
10
Public Issue
21-Aug-2023
1.54
15.44
2500000
10
Preferential basis
22-Aug-2022
1.29
12.94
40000
10
Right Issues
31-Mar-2022
1.29
12.90
8602000
10
Bonus Issue
25-Mar-2015
43.01
4.30
1337000
10
Right Issues
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Nitin Jasvantbhai Patel (15.71%)

Highest Public shareholder

Kantilal Pachan Vadia (8.43%)

Individual Investors Holdings

35.49%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Material Consumed
112.0379
0%
 
100
Cost of Material Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
59 Cr
(Quarterly Results - Mar 2023)
Net Profit:
7 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR Cr (Micro Cap)

stock-summary
P/E

24.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00